India's cheap weight-loss drugs could reshape global obesity fight

📅 Published: March 18, 2026 | 📂 Category: Top Stories

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

📱 Share on WhatsApp 🌐 View Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *